Business Day TV spoke to Ascendis Health CEO Mark Sardi about the company’s full-year results
01 October 2021 - 08:09
byBusiness Day TV
Support our award-winning journalism. The Premium package (digital only) is R30 for the first month and thereafter you pay R129 p/m now ad-free for all subscribers.
High debt levels, restructuring costs, rising finance charges and the Covid-19 pandemic have all weighed on Ascendis Health’s annual performance as its loss per share from total operations widened to 226.5c.
But the company is now charting a course with slimmed down operations after a restructuring plan left it with just three SA businesses.
Support our award-winning journalism. The Premium package (digital only) is R30 for the first month and thereafter you pay R129 p/m now ad-free for all subscribers.
NEWS LEADER
WATCH: What lies ahead for Ascendis Health
Business Day TV spoke to Ascendis Health CEO Mark Sardi about the company’s full-year results
High debt levels, restructuring costs, rising finance charges and the Covid-19 pandemic have all weighed on Ascendis Health’s annual performance as its loss per share from total operations widened to 226.5c.
But the company is now charting a course with slimmed down operations after a restructuring plan left it with just three SA businesses.
Business Day TV spoke to Ascendis Health CEO Mark Sardi about the company’s performance.
Ascendis could be poised for ‘strategic pivot’ to go private
Ascendis inks R770m deal to sell its animal-health division
WATCH: Why Ascendis has agreed to a debt-for-asset swap
Companies in this Story
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Most Read
Published by Arena Holdings and distributed with the Financial Mail on the last Thursday of every month except December and January.